IeDEA Consortium publishes journal supplement on research priorities for achieving universal HIV treatment in sub-Saharan Africa

Nearly all countries in sub-Saharan Africa (SSA) have adopted national polices for universal HIV treatment, regardless of CD4 cell count or clinical stage. Evidence to date from SSA suggests that, once linked to care, timely ART initiation with retention and viral suppression is the norm. However, ART initiation in SSA usually occurs late in the course of infection, driving up mortality and new infection rates. With 10.3 million people untreated and a projected 1.2M new infections per year in SSA, the universal treatment era presents strategic opportunities for health systems to substantially reduce AIDS-related mortality and HIV incidence. This special issue of the Journal of Virus Eradication, with contributing authors from the African regions of the IeDEA consortium and the World Health Organization (WHO), contains an editorial and eight articles focused on issues critical to ensuring the success and impact of universal treatment implementation in SSA.

For the complete edition and all articles click here

Adherence 2019 – Registration and abstract submission now open

Adherence 2019 will take place June 17-19, 2019, at the Loews Miami Beach Hotel in Miami, FL, USA. Sponsored by the International Association of Providers of AIDS Care (IAPAC), this annual series of conferences features the presentation and discussion of HIV treatment and biomedical prevention adherence research, and current behavioral and clinical perspectives in practicum, within the context of optimizing the continuum of HIV care and prevention. Adherence 2019 will also feature an implementation science track focused on closing gaps between evidence and routine practice for health in real-world settings.

For more information and registration/abstract submission please click here

Call for Research Fellowship Applications in Cape Town, South Africa

The Desmond Tutu HIV Foundation (DTHF) at the University of Cape Town, in partnership with the International AIDS Vaccine Initiative (IAVI), invites ambitious African research fellows to undertake adolescent research in an exciting flagship HIV research programme.

Apply here for a fully funded opportunity to contribute to adolescent HIV/TB research, in Cape Town, South Africa.

UCT CIDER made WHO Collaborating Centre for HIV Epidemiology and Research

The Centre for Infectious Diseases Epidemiology & Research (CIDER) in the School of Public Health & Family Medicine at the University of Cape Town has been made the World Health Organization (WHO) Collaborating Centre for HIV Epidemiology and Research. The Collaborating Centre is based on CIDER’s longstanding contributions to WHO policy through research and innovation, including in the areas of health information systems, epidemiology of HIV/AIDS, and analyses of patients receiving antiretroviral therapy (ART).

This is a major accomplishment for the CIDER team, and the four-year term of the Collaborating Centre will see continued work with WHO to strengthen international policies in these areas.